The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation
- 31 January 1991
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 31 (1) , 83-88
- https://doi.org/10.1016/0165-5728(91)90090-t
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and PolyneuropathyNew England Journal of Medicine, 1990
- Molecular cloning of a human immunoglobulin heavy chain variable (V ) region with anti-myelin-associated glycoprotein activityJournal of Neuroimmunology, 1990
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1989
- Demyelination induced by intraneural injection of human antimyelin‐associated glycoprotein antibodiesMuscle & Nerve, 1988
- Normal, Autoimmune, and Malignant CD5+ B Cells: The LY-1 B Lineage?Annual Review of Immunology, 1988
- The LY‐1B Cell LineageImmunological Reviews, 1986
- Neuropathy and anti‐myelin‐associated glycoprotein IgM M proteins: T cell regulation of M protein secretion in vitroAnnals of Neurology, 1985
- Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in PolyneuropathyJournal of Neurochemistry, 1982
- A unique cell surface antigen identifying lymphoid malignancies of B cell origin.Journal of Clinical Investigation, 1981